[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20064715L - Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C) - Google Patents

Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)

Info

Publication number
NO20064715L
NO20064715L NO20064715A NO20064715A NO20064715L NO 20064715 L NO20064715 L NO 20064715L NO 20064715 A NO20064715 A NO 20064715A NO 20064715 A NO20064715 A NO 20064715A NO 20064715 L NO20064715 L NO 20064715L
Authority
NO
Norway
Prior art keywords
renalase
isolation
monoamine oxidase
detection
oxidase
Prior art date
Application number
NO20064715A
Other languages
English (en)
Inventor
Jianchao Xu
Gary Desir
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of NO20064715L publication Critical patent/NO20064715L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03004—Monoamine oxidase (1.4.3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse tillater identifisering, isolering og anvendelser av mammalsk Monoamin oksidase C (MAO-C), også kjent som renalase.
NO20064715A 2004-03-19 2006-10-18 Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C) NO20064715L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55455204P 2004-03-19 2004-03-19
US61545204P 2004-10-01 2004-10-01
PCT/US2005/009248 WO2005089505A2 (en) 2004-03-19 2005-03-21 Detection, isolation and uses of renalase (monoamine oxidase c)

Publications (1)

Publication Number Publication Date
NO20064715L true NO20064715L (no) 2006-11-20

Family

ID=34994397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064715A NO20064715L (no) 2004-03-19 2006-10-18 Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)

Country Status (8)

Country Link
US (3) US7700095B2 (no)
EP (1) EP1786833A4 (no)
JP (1) JP4773424B2 (no)
AU (1) AU2005223847A1 (no)
CA (1) CA2559211A1 (no)
EA (1) EA200601743A1 (no)
NO (1) NO20064715L (no)
WO (1) WO2005089505A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8280136B2 (en) * 2005-09-16 2012-10-02 The Ohio State University Method and apparatus for detecting intraventricular dyssynchrony
EP1933703A2 (en) * 2005-09-16 2008-06-25 The Ohio State University Method and apparatus for detecting interventricular dyssynchrony
JP2009516693A (ja) * 2005-11-21 2009-04-23 イエール ユニバーシティ レナラーゼ（モノアミンオキシダーゼｃ）の調節方法
WO2008091408A2 (en) * 2006-09-25 2008-07-31 Yale University Circulating renalase and methods of increasing same
US10066025B2 (en) * 2012-07-16 2018-09-04 Yale University Compositions and methods for detecting, treating and preventing diseases and disorders
WO2014043170A1 (en) 2012-09-11 2014-03-20 Corning Incorporated Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter proteins(s) and/or drug metabolizing enzyme(s)
EP3718539A1 (en) * 2013-04-18 2020-10-07 The Regents of the University of California Nanoscale coatings for encapsulation of biological entities
WO2015175884A2 (en) 2014-05-16 2015-11-19 Yale University Compositions and methods for treating and preventing pancreatitis, renal injury and cancer
EP3160493A4 (en) 2014-06-26 2018-04-11 Yale University Compositions and methods to regulate renalase in the treatment of diseases and disorders
CN114107156B (zh) * 2021-11-29 2023-06-02 江南大学 高效生产戊二酸的重组大肠杆菌及其构建方法与应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
ES2224375T3 (es) 1997-04-14 2005-03-01 Cell Genesys, Inc. Metodos para aumentar la eficacia del producto de aav recombinante.
US5932465A (en) * 1997-10-16 1999-08-03 Icos Corporation Phosphodiesterase 8A
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP2002520050A (ja) 1998-07-15 2002-07-09 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ７１個のヒト分泌タンパク質
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
JP2002191363A (ja) * 1999-07-29 2002-07-09 Herikkusu Kenkyusho:Kk 全長ｃＤＮＡ合成用プライマー、およびその用途
EP1198574A2 (en) 1999-08-04 2002-04-24 PHARMACIA & UPJOHN COMPANY Soluble, active recombinant human mao-b
WO2001057190A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
US20020132237A1 (en) 2000-05-26 2002-09-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2002068579A2 (en) 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US20040005685A1 (en) * 2002-06-05 2004-01-08 Millennium Pharmaceuticals, Inc. 97316, a human amine oxidase family member and uses therefor
US20060286078A1 (en) * 2005-06-15 2006-12-21 Humes H D Methods of treating cardiorenal syndrome and hepatorenal syndrome
JP2009516693A (ja) * 2005-11-21 2009-04-23 イエール ユニバーシティ レナラーゼ（モノアミンオキシダーゼｃ）の調節方法

Also Published As

Publication number Publication date
US7700095B2 (en) 2010-04-20
EP1786833A2 (en) 2007-05-23
US20070275083A1 (en) 2007-11-29
JP4773424B2 (ja) 2011-09-14
US20130273023A1 (en) 2013-10-17
EP1786833A4 (en) 2009-02-25
WO2005089505A3 (en) 2007-08-02
US20100136651A1 (en) 2010-06-03
US7932067B2 (en) 2011-04-26
EA200601743A1 (ru) 2007-08-31
CA2559211A1 (en) 2005-09-29
WO2005089505A2 (en) 2005-09-29
AU2005223847A1 (en) 2005-09-29
JP2007531518A (ja) 2007-11-08

Similar Documents

Publication Publication Date Title
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
NO20081042L (no) PPAR aktive forbindelser
EA200701918A1 (ru) Белок липокалин
WO2007055714A3 (en) Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
NO20090047L (no) Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse
DK1409459T3 (da) ECL mærker, som har forbedrede, non-specifikke bindingsegenskaber, fremgangsmåder til anvendelse deraf, og kits indeholdende samme.
ATE497492T1 (de) Reinigung von montelukast
TW200622950A (en) Methods of monitoring the concentration of an analyte
MXPA06011046A (es) Ciertos compuestos basados en triazol, composiciones, y usos de los mismos.
NO20083153L (no) Kjemiske forbindelser
NO20070263L (no) Immunostimulerende oligonukleotidmultimerer
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20082305L (no) Mikrobiologisk stabilisert ol
WO2007098184A3 (en) Methods and compositions for analyte detection
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
TW200621253A (en) 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
TNSN07196A1 (en) Potentiators of glutamate receptors
WO2007120699A3 (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals
TW200718687A (en) Inhibitors of cytosolic phospholipase A2
BRPI0414599A (pt) pirrol-indóis substituìdos
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
TW200624426A (en) BACE inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application